clopidogrel 75mg, Atorvastetin 20mg Tablet
Agron Remedies - Leading Global Pharmaceutical Company.
Product Description:
Clopidogrel 75mg + Atorvastatin 20mg Tablets, manufactured by Agron Remedies, are a powerful dual-action cardiovascular medicine combining an antiplatelet agent (Clopidogrel) and a statin (Atorvastatin).
Clopidogrel works by preventing platelet aggregation and clot formation, while Atorvastatin helps lower bad cholesterol (LDL) and triglycerides and increases good cholesterol (HDL).
This combination reduces the risk of heart attack, stroke, and atherosclerotic complications in patients with cardiovascular diseases or high cholesterol levels.
MRP: ₹1850
Packing: 10x10 ALU-ALU
Type: Tablets
Manufactured in WHO-GMP & ISO 9001:2015 certified facilities, ensuring safe, effective, and high-quality formulations.
Indications:
Clopidogrel + Atorvastatin Tablets are indicated for:
-
Prevention of heart attack and ischemic stroke
-
Management of dyslipidemia and hypercholesterolemia
-
Secondary prevention in patients with coronary artery disease (CAD)
-
Post-angioplasty or coronary stent care
-
Atherosclerosis and other cardiovascular complications
Dosage & Administration:
-
Adults: One tablet once daily or as directed by a physician.
-
Route: Oral administration.
-
Instructions:
-
Take with water, preferably after meals.
-
Do not crush or chew the tablet.
-
Continue the course as prescribed by your doctor.
-
Maintain a low-fat diet and avoid alcohol during treatment.
-
Storage:
-
Store below 25°C in a cool, dry place.
-
Protect from direct sunlight and moisture.
-
Keep out of reach of children.
Disclaimer:
The information above is for educational purposes only and not a substitute for professional medical advice. Clopidogrel 75mg + Atorvastatin 20mg Tablets should be used only under the supervision of a qualified healthcare professional. Do not self-medicate or change your dosage without consulting your doctor. Agron Remedies is not liable for any misuse, adverse effects, or off-label use of this medication.